Adial Pharmaceuticals ADIL Q1 2026 earnings
Reported May 8, 2026 · After market close
EPS-$1.48Beat by $1.25
EPS estimate-$2.73
Next report
Aug 12, 2026 (In 1 week)EPS estimate-$1.02
Versus estimates
Diluted EPS
Ask the moment Adial Pharmaceuticals reports.
Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.
Connect your AI
Claude
Questions, answered.
- When did Adial Pharmaceuticals report Q1 2026 earnings?
- Adial Pharmaceuticals (ADIL) reported Q1 2026 earnings on May 8, 2026 after market close.
- What were Adial Pharmaceuticals's Q1 2026 revenue and EPS?
- Adial Pharmaceuticals reported eps of $-1.48 for Q1 2026.
- Did Adial Pharmaceuticals beat estimates in Q1 2026?
- EPS beat the consensus estimate of $-2.73 by $1.25.
- How did Adial Pharmaceuticals's Q1 2026 results compare year-over-year?
- Compared to the same quarter a year prior, eps declined 335.3% from $-0.34.
- Where can I find Adial Pharmaceuticals's Q1 2026 SEC filings?
- You can read the 10-Q periodic report (0001213900-26-053907) directly on SEC EDGAR. The filing index links above go to sec.gov.